CompletedNot Applicable

Pubertal Replacement In Boys Study Nebido and Testoviron Depot Treatment

27 participantsStarted 2014-06-01

Plain-language summary

In this prospective open clinical study, Pubertal Replacement in Boys Study (PRIBS), boys 14-16 years with delayed puberty in terms of slow pubertal progression, were randomized to SoC treatment with TE: Testostoviron depot® 75 mg intramuscularly (i.m) / month (6 injections), or low dose TU: Nebido® 250mg i.m. / 3 months (2 injections). Our goal was to implement a study similar to clinical routine.

Who can participate

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Signed informed consent * Two morning testosterone values (07.30-09.00) of 1-3 nmol/L and at start \< 4 mmol/L ¹ * Testicular volume 4-6 mL bilaterally² Exclusion Criteria: * • Growth spurt * Untreated hypothyroidism, celiac disease or steroid medication * Training doses \> 10 hours a week * Use of anabolic steroids or other drugs

What they're measuring

Testicular Volume 8ml

Timeframe: 12 months after induction

Trial details

NCT IDNCT05417035

SponsorNU-Hospital Organization, Sweden

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-01

View on ClinicalTrials.gov More Puberty Delayed trials